SMOT ETF Quarterly Reconstitution 3Q2023
27 September 2023
Read Time 2 MIN
The Morningstar® US Small-Mid Cap Moat Focus IndexSM (the “SMID Moat Index”) underwent its quarterly review on September 15, 2023 in which it systematically targets attractively priced, high quality small- and mid-cap U.S. companies. Below are some key takeaways from the September review and how the SMID Moat Index is positioned as we enter the last quarter of the year.
Key Takeaways:
- Technology Companies Lead in Removals
The Index removed a notable number of technology companies during this quarter’s review. In all, seven technology names were removed, including Crane NXT, Blackbaud, Guidewire Software, Monolithic Power Systems, Verisign, and WorkDay. Almost all of these removals were due to the Index’s valuation screen, signaling that this segment of the U.S. market may be overvalued.
- Value Exposure Decreased in Favor of Growth
Despite the SMID Moat Index’s removal of several technology companies, the style exposure within the Index still shifted slightly toward growth this quarter. The shift came primarily at the cost value which saw a reduction in exposure this quarter. Total growth exposure for the Index now stands at about 26%, but remains a minor underweight of about 3% relative to the broad SMID-cap universe1.
- Consumer Discretionary and Health Care Additions
Companies belonging to the consumer discretionary and health care sectors were notable additions this quarter with twelve names between the two sectors added to the Index. DoorDash, Harley-Davidson and Wynn Resorts, among others accounted for the consumer discretionary additions, while health care saw names added like Veeva Systems, DaVita, and Agilent Technologies cycle. Both sectors are overweights in the SMID Moat Index relative to the broad SMID-cap universe1.
Access Quality Companies and Attractive Valuations
VanEck Morningstar SMID Moat ETF (SMOT) seeks to track as closely as possible, before fees and expenses the price and yield performance of the Morningstar US Small-Mid Cap Moat Focus Index.
1 Broad SMID-cap Universe represented by the Morningstar US Small–Mid Cap Index which consists of US stocks representing the bottom 27 percent capitalization of the investable universe.
Related Insights
This material may only be used outside of the United States.
This is not an offer to buy or sell, or a recommendation of any offer to buy or sell any of the securities mentioned herein. Fund holdings will vary. For a complete list of holdings in VanEck Mutual Funds and VanEck ETFs, please visit our website at www.vaneck.com.
The information presented does not involve the rendering of personalized investment, financial, legal, or tax advice. Certain statements contained herein may constitute projections, forecasts and other forward looking statements, which do not reflect actual results. Information provided by third-party sources are believed to be reliable and have not been independently verified for accuracy or completeness and cannot be guaranteed. Any opinions, projections, forecasts, and forward-looking statements presented herein are valid as of the date of this communication and are subject to change without notice. The information herein represents the opinion of the author(s), but not necessarily those of VanEck.
The views contained herein are not to be taken as advice or a recommendation to buy or sell any investment in any jurisdiction, nor is it a commitment from Van Eck Associates Corporation or its subsidiaries to participate in any transactions in any companies mentioned herein. This content is published in the United States. Investors are subject to securities and tax regulations within their applicable jurisdictions that are not addressed herein.
All investing is subject to risk, including the possible loss of the money you invest. As with any investment strategy, there is no guarantee that investment objectives will be met and investors may lose money. Diversification does not ensure a profit or protect against a loss in a declining market. Past performance is no guarantee of future results.